Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Episodes 1-16 of 132
- Global Neurology Academy
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
Charles Turck, PharmD, BCPS, BCCCP
Yinan Zhang, MD
Sarah A. Morrow, MD, MS, FRCPC, FAAN
- Global Neurology Academy
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
Charles Turck, PharmD, BCPS, BCCCP
Kimberly DiMauro, DO
Carol Swetlik, MD
Marisa McGinley, DO
- Global Neurology Academy
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
Joseph F. Goldberg, MD
Joseph F. Goldberg, MD
Michael G. Dwyer, PhD
Michael G. Dwyer, PhD
Michael G. Dwyer, PhD
Beth Ann Malow, MD, MS
Jennie Taylor, MD
Lauren Schaff, MD
Jennie Taylor, MD
Charles Turck, PharmD, BCPS, BCCCP
Kaitlin Batley, MD
Esra Caylan, MD
Hans Katzberg, MD
- Global Neurology Academy
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
Sami Khella, MD
- Prev
- Next